Detalhe da pesquisa
1.
ESR1 gene amplification and MAP3K mutations are selected during adjuvant endocrine therapies in relapsing Hormone Receptor-positive, HER2-negative breast cancer (HR+ HER2- BC).
PLoS Genet
; 19(1): e1010563, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36595552
2.
Standardised definitions and diagnostic criteria for extranodal extension detected on histopathological examination in head and neck cancer: Head and Neck Cancer International Group consensus recommendations.
Lancet Oncol
; 25(7): e286-e296, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38936387
3.
Real-world use of multigene signatures in early breast cancer: differences to clinical trials.
Breast Cancer Res Treat
; 205(1): 39-48, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38265569
4.
Correlation between radiological and biological features and clinical outcomes in early prostate cancer: an exploratory subgroup analysis.
Neoplasma
; 69(2): 404-411, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35014537
5.
Clinical performance of contrast-enhanced spectral mammography in pre-surgical evaluation of breast malignant lesions in dense breasts: a single center study.
Breast Cancer Res Treat
; 184(3): 723-731, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32860166
6.
Prognostic and predictive value of cell cycle progression (CCP) score in ductal carcinoma in situ of the breast.
Mod Pathol
; 33(6): 1065-1077, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31925342
7.
Endocrine-responsive lobular carcinoma of the breast: features associated with risk of late distant recurrence.
Breast Cancer Res
; 21(1): 153, 2019 12 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31888717
8.
Oncological Outcomes of Nipple-Sparing Mastectomy: A Single-Center Experience of 1989 Patients.
Ann Surg Oncol
; 25(13): 3849-3857, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30225833
9.
Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research.
Adv Anat Pathol
; 24(5): 235-251, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28777142
10.
Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors.
Adv Anat Pathol
; 24(6): 311-335, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28777143
11.
Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00.
Breast Cancer Res Treat
; 158(2): 323-31, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27372069
12.
Biomarkers for the identification of recurrence in human epidermal growth factor receptor 2-positive breast cancer patients.
Curr Opin Oncol
; 28(6): 476-483, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27649027
13.
A gene expression-based classifier for HER2-low breast cancer.
Sci Rep
; 14(1): 2628, 2024 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38297001
14.
Association of a gene-expression subtype to outcome and treatment response in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab.
J Immunother Cancer
; 12(1)2024 01 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38290766
15.
Long-term Multimodal Recording Reveals Epigenetic Adaptation Routes in Dormant Breast Cancer Cells.
Cancer Discov
; 14(5): 866-889, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38527495
16.
The clinical relevance of micropapillary carcinoma of the breast: a case-control study.
Histopathology
; 63(2): 217-24, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23763700
17.
Can we define breast cancer HER2 status by liquid biopsy?
Int Rev Cell Mol Biol
; 381: 23-56, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37739483
18.
Fatty acid synthase as a new therapeutic target for HER2-positive gastric cancer.
Cell Oncol (Dordr)
; 46(3): 661-676, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36753044
19.
Breast cancers arising in subjects with germline BRCA1 or BRCA2 mutations: Different biological and clinical entities with potentially diverse therapeutic opportunities.
Crit Rev Oncol Hematol
; 190: 104109, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37643668
20.
Pan-TRK immunohistochemistry as screening tool for NTRK fusions: A diagnostic workflow for the identification of positive patients in clinical practice.
Cancer Biomark
; 38(3): 301-309, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37545217